RENB

RENB

USD

Renovaro Inc. Common Stock

$1.420+0.230 (19.328%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.190

Kõrge

$1.420

Madal

$1.420

Maht

0.12M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

33.8M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.22M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $1.11Praegune $1.420Kõrge $21

Seotud uudised

AccessWire

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Measure taken to Comply with Nasdaq Rule 5550 Regarding Minimum Bid Price LOS ANGELES, CA / ACCESS Newswire / September 24, 2025 / Lunai Bioworks, Inc. ("Lunai Bioworks" or the

Vaata rohkem
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split
AccessWire

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

BETHESDA, MD / ACCESS Newswire / September 11, 2025 / Lunai Bioworks Inc.'s wholly-owned subsidiary BioSymetrics Inc. today announced the award of a prestigious Small Business Technology Transfer

Vaata rohkem
Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics
AccessWire

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Lunai Bioworks Inc. , an AI-powered drug

Vaata rohkem
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
AccessWire

Lunai Bioworks Strengthens European Strategy Through Restructuring

Company remains committed to Europe with a streamlined, growth-focused approach. LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 8, 2025 / Lunai Bioworks Inc. , an AI-powered drug discovery and

Vaata rohkem
Lunai Bioworks Strengthens European Strategy Through Restructuring